CXCR4 polymorphism predicts progression-free survival in metastatic colorectal cancer patients treated with first-line bevacizumab-based chemotherapy
暂无分享，去创建一个
H. Lenz | W. Zhang | S. Okazaki | D. Yang | Dongyun Yang | W. Ichikawa | S. Stremitzer | F. Loupakis | S. Matsusaka | S. Stintzing | M. Ueno | M. D. Berger | S. Cao | Y. Ning | Y. Sunakawa | S. Yamauchi | D. Hanna | N. Mizunuma | A. Mendez | R. El-khoueiry | A. Parekh | A. Sebio | S. Stintzing | S. Yamauchi | Wataru Ichikawa | Masashi Ueno